[Edaily Reporter Kwon Oh Seok ] TBH GLOBAL(084870)is accelerating the popularization of K-fashion by expanding its Daiso-exclusive “BASIC HOUSE+” lineup to include pants. (Photo = TBH GLOBAL) TBH GLOBAL announced on the 6th that it has added three new styles of shorts to the “BASIC HOUSE+” line, which is sold exclusively at Daiso. This supply follows the second batch and is notable for expanding the product lineup—previously centered on short-sleeve T-shirts—to include pants. The newly introduced products—Bermuda shorts, sweat shorts, and women’s three-quarter-length pants—are designed to offer both practicality and style, focusing on basic items that can be comfortably worn in everyday summer life. Basic House Plus is a product line that brings together basic items with high everyday utility at reasonable prices; it targets a broad consumer base by emphasizing trend-conscious designs and consistent quality. TBH GLOBAL previously received positive reviews for its T-shirt lineup, which offered various silhouettes such as regular fit, relaxed fit, and layered fit. The company explained that it proved its brand competitiveness as some products became so popular that they were described as causing “sell-out frenzy.” The company plans to expand the range of top-and-bottom outfit options through this expansion of its pants lineup, thereby further enhancing the product appeal and customer engagement of Basic House Plus within the Daiso channel. A TBH GLOBAL representative stated, “This pants line is designed to offer both comfort and style for the summer season, and we expect it to generate significant interest.”
ABLE C&C(078520)is establishing a subsidiary in the Netherlands to serve as the control tower for its European operations. Following the establishment of its UK subsidiary, the company is setting up a…
On the afternoon of the 18th, at the Vuori pop-up store in Seongsu-dong, Seongdong-gu, Seoul, a different scene unfolded as I passed through the first and second floors—where clothes were displayed—an…
As global Big Pharma companies embark on large-scale mergers and acquisitions (M&A) to overcome the patent cliff and growth limitations, there are increasing instances of Chinese biotech companies bei…